The heterogeneous nature of the mechanisms underlying neuropathic pain complicates the selection of appropriate treatments for individual patients. Although systematic reviews have outlined the ...
Grünenthal announced today that its U.S. subsidiary, Averitas Pharma, Inc., has completed recruitment for the Phase III clinical trial AV001. The trial investigates the efficacy, safety and ...
If you’re new to CBD, it’s best to start with ... needed before experts can conclude CBD is an effective treatment for nerve-related pain. The CBD world is filled with a lot of claims and ...
European researchers have mapped the most comprehensive phenotyping of neuropathic pain and identified ... improving patient quality of life and treatment outcomes. New research describes for ...
Find out about the groundbreaking MDMA clinical trial for chronic nerve pain. Discover how this study aims to test the impact of MDMA compared to a placebo.
New treatments that could help tackle chronic ... which chemotherapy causes patients to experience ongoing pain by damaging nerve cells, as part of a two-year study funded by the Medical Research ...
These unexplained cases are called cryptogenic sensory polyneuropathy (CSPN), where the cause of the nerve pain remains unknown. For people with CSPN, finding effective treatment can be ...